- Benchmark, the biotechnology and food chain sustainability business, says its performance for the six months to 31 March was in line with management's expectations.

The integration of INVE is progressing well, with operational synergies being realised through utilisation of INVE's distribution network to support the launch of the first of our new aquaculture vaccines from the Animal Health pipeline, and use of INVE's products in the Breeding and Genetics division's lumpfish programme. The Advanced Animal Nutrition division performed slightly ahead of management's expectations.

The Animal Health, Sustainability Science and Technical Publishing divisions all performed in line with management's expectations.

Benchmark expects to announce its interim results for the six months to 31 March on 28 June.

Chief executive Malcolm Pye said: "We have had a busy first half and made significant progress as we continue to develop Benchmark into a group that comprehensively serves the needs of our customers. The quality of our divisional management teams has been evident during the integration of INVE as they continue their work to realise synergies available to the enlarged Group.

"Our strategy of diversification is showing its value and importance, with half year performance in line with our expectations, despite the disruption caused by the border situation in Chile.

"Having completed the process of creating a scalable group structure, the outlook for Benchmark is extremely promising. The markets we serve are not transitory, but are the fundamental building blocks of a sustainable food chain. With all of the pressures being placed upon these industries, we are an increasingly important partner to our customers. Against this backdrop, we will continue our work to achieve our long term potential and create value, by launching the new products our customers urgently need and growing sales."

At 9:31am: [LON:BMK] Benchmark Holdings Plc Ord 0.1p share price was 0p at 53p

Story provided by